BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics

Sustainalytics' ESG Risk Ratings evaluate over 14,000 companies across 42 industries worldwide, measuring each company's exposure to industry-specific mate...

March 15, 2022 | News

China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors

-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...

March 14, 2022 | News

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric and neurological conditions. Terra...

March 13, 2022 | News

Molecular Health collaborates to explore the molecular causation of adverse drug reactions

Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that d...

March 11, 2022 | News

Novavax Announces Launch of Global Vaccine Education Programs

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

March 11, 2022 | News

Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to id...

March 08, 2022 | News

Paras Biopharmaceuticals to expand global outreach of its ‘Biosimilar Development & Partnership’

Bioseet, based in Munich, Germany, is an enterprise encompassing a virtual marketplace and teamspace for Biosimilar and other generic assets to facilitate ...

March 03, 2022 | News

Cambrex Expands Biopharmaceutical Services Business

The expansion includes 11 additional cGMP laboratories at Cambrex's Durham, NC facility and broadens its service offering for large molecul...

March 01, 2022 | News

Avivagen Announces Approval in Vietnam

“We are very excited to secure approval for our product in Vietnam, a critical feed market in Southeast Asia with strong growth potential over the co...

February 24, 2022 | News

Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345

Since Innovent announced its strategic cooperation with Roche on June 9, 2020, this is the first disclosure of the development milestone for the cell ...

February 21, 2022 | News

Thermo Fisher Scientific Expands Millersburg, Pa. Bioprocessing Manufacturing Site

hermo Fisher Scientific is investing $40 million to expand its single-use technology (SUT) manufacturing facility in Millersburg, Pa. The expansion is part...

February 18, 2022 | News

Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries

Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its comme...

February 16, 2022 | News

Bactiguard and Zimmer Biomet expand global license partnership

The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), sports medicine, craniomaxillofacial and thoracic appli...

February 09, 2022 | News

Singapore (HSA) approval marks the first in a series of expected approvals of Trodelvy in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative ph...

February 07, 2022 | News

Stay Connected